Loading clinical trials...

Virological Response Study of the HCV Vaccine IC41 | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00601770

Virological Response Study of the HCV Vaccine IC41

The objective is to investigate the virological (HCV-RNA) responses following biweekly immunization with IC41. Treatment phase 14 weeks, total study duration including follow-up period 38 weeks.

Lead sponsor: Valneva Austria GmbH•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

The Efficacy of Vosevi in Treating DAA-experienced Patients

NCT06180590 · Chronic Hepatitis C, Medication Reaction

Active Not Recruiting

Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong

NCT03993925 · Chronic Hepatitis C, Intravenous Drug Usage

COMPLETEDPhase 2

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM

NCT00199719 · Chronic Hepatitis C

COMPLETEDPhase 4

Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital

NCT06922643 · Chronic Hepatitis C

COMPLETED

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

NCT02578693 · Chronic Hepatitis C Infection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment71

Start dateFeb 2006

Last updatedFeb 11, 2014

Condition

Chronic Hepatitis C

Locations shown

Prof. Dr. Ulrich Spengler

Bonn, Bonn

Prof. Dr. Michael Manns

Hanover, Hannover

Dr. Granzyna Cholewinska-Szymanska

Warzawa, Warzawa

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions